Bioavailability Study in Healthy Participants, 200mg Tablets ZSP1273 Versus 200mg Granules ZSP1273
Clinical trial NCT06164431 · COMPLETED
Trial details
- NCT number
- NCT06164431
- Sponsor
- Guangdong Raynovent Biotech Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-23
- Primary completion
- 2023-12-15
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.